Björn Schröder's research group has received SEK 6 million in grants from the Erling Persson Foundation for research on the intestinal microbial modulation of mucus in ulcerative colitis.
MIMS
The Laboratory for Molecular Infection Medicine Sweden
MIMS is the Swedish partner in the Nordic EMBL Partnership for Molecular Medicine
Image:
Mattias Pettersson
Calls open soon!
MIMS Group Leader in Molecular Infection Medicine
Attractive Group Leader package at MIMS, the Swedish EMBL node. EMBL Group Leader model with long-term funding for up to 9 years. All areas in basic molecular infection medicine research are welcome, especially those in virology, or needing access to cryo-EM or animal BSL3 facility.
Preliminary timeline: application period opens in November 2024, and closes in February 2025.
NORPOD Postdoc Fellows
Stay tuned for the upcoming launch of the next NORPOD Postdoctoral Programme in molecular medicine, offering research opportunities in the Nordics. Don't miss your chance to be part of an innovative and collaborative community!
Find more information on the Nordic EMBL Partnership website.
Persson millions for intestinal research
Important new funding for research on virus factories
Lars-Anders Carlson, MIMS Investigator, received SEK 24 million from the Knut and Alice Wallenberg Foundation to understand how the virus factories that are built up in our cells work.
MIMS Group Leader awarded ERC Starting Grant
MIMS Group Leader Iker Valle Aramburu has been awarded funding for his research project "Illuminating the dark microproteome in innate immunity’, is about identifying and studying the role of microproteins in innate immune cells".
Discovery at Umeå University awarded 2020 Nobel Prize in Chemistry
Research Areas
Discover the different research areas MIMS scientists are engaged with
Our Stories
Read the latest stories about our research and researchers
Work With Us
Find out what open position are available
Nordic EMBL Partnership for Molecular Medicine
Supporting organisations
